Richard A. Heyman is Director of YUMANITY THERAPEUTICS, INC.. Currently has a direct ownership of 8,117 shares of YMTX, which is worth approximately $0. The most recent transaction as insider was on Feb 01, 2021, when has been sold 1,959 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.12K
0% 3M change
0% 12M change
Total Value Held $0

Richard A. Heyman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 01 2021
BUY
Grant, award, or other acquisition
-
1,959 Added 19.44%
8,117 Common Stock
Dec 22 2020
BUY
Grant, award, or other acquisition
-
6,158 Added 50.0%
6,158 Common Stock

Also insider at

PMVP
PMV Pharmaceuticals, Inc. Healthcare
ORIC
Oric Pharmaceuticals, Inc. Healthcare
MTCR
Metacrine, Inc. Healthcare
GRTS
Gritstone bio, Inc. Healthcare
IMRA
IMARA Inc. Healthcare
RYZB
RayzeBio, Inc.
RAH

Richard A. Heyman

Director
San Diego, CA

Track Institutional and Insider Activities on YMTX

Follow YUMANITY THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells YMTX shares.

Notify only if

Insider Trading

Get notified when an Yumanity Therapeutics, Inc. insider buys or sells YMTX shares.

Notify only if

News

Receive news related to YUMANITY THERAPEUTICS, INC.

Track Activities on YMTX